Industries > Pharma > Global Inhalation Anaesthesia Market Report 2019-2029
Global Inhalation Anaesthesia Market Report 2019-2029
Analysis by Product Type (Sevoflurane, Desflurane, Isoflurane), Application (Induction, Maintenance), Plus Company and Country Analysis and Forecasts
Market Definition:
• Inhalational anesthesia (IA) become the anesthetic of choice over Intravenous Anesthesia (IVA) among majority of healthcare practitioners, as it helps avoid excessive dosage and keeps the patient’s autonomic functions intact. IA has lower risk of delirium and is cost effective compared to IVA
• Inhalational anesthesia used for sedation as well as for the induction and maintenance of general anesthesia. The most common inhalational anesthetics are sevoflurane, desflurane, and nitrous oxide.
Market Overview and Trends
• To address the environmental impact of anesthetic gases, new technologies are being developed to scavenge them from hospital vents and recycle them.
• These anesthetic gases contribute up to 1.0% of global carbon dioxide emissions, leading to greater environmental damage.
• The major concern in using anesthetic gases is that patient use accounts for only 5.0% and the rest 95.0% is released into the atmosphere which contributes to global warming
Market Dynamics:
Factors Influencing the Market Growth:
• Rapid rise in aging population suffering from cancer, cardiovascular, spinal, orthopedic, respiratory, gastrointestinal, neurological, and other diseases and disorders is anticipated to drive the growth
• Increasing number of emergency cases and accidents are also expected to positively influence market growth
• Increasing number of orthopedic procedures such as ligament and other soft tissue repair procedures is also contributing to growth of the day care ambulatory surgeries, which is expected to boost usage of inhalation anesthesia.
Factors Restraining the Market Growth:
• Inhalational anesthetics cause respiratory depression, a decrease in arterial blood pressure and cerebral metabolic demand, and an increase in cerebral blood flow that may hinder the growth of the market.
Market Segmentation 2019-2029:
The inhalation anesthesia market is segmented on the product type, application, and geography.
Product Type
• Sevoflurane Market, 2019-2029
• Desflurane Market, 2019-2029
• Isoflurane Market, 2019-2029
Application
• Induction Market, 2019-2029
• Maintenance Market, 2019-2029
Geographic Breakdown
Focused regional forecasts and analysis explore the future opportunities:
• North America Market, 2019-2029
• Europe Market, 2019-2029
• Asia-Pacific Market, 2019-2029
• LAMEA Market, 2019-2029
Competitive Analysis:
• Research and development is the primary strategy adopted by the key players in the inhalation anesthesia market.
• These companies have developed various strategies and developments such as product launch, partnerships, mergers & acquisitions, joint venture, and collaborations.
• Baxter Healthcare is the only player with all the 3 products in its portfolio. AbbVie Inc. has sevoflurane and isoflurane in its portfolio. Piramal Healthcare presently has sevoflurane and isoflurane in its portfolio and may capture a significant market share of Baxter in the years to come owing to new product launches
Major Market Players:
Halocarbon Products Corporation; Hikima Pharmaceuticals PLC; Lunan Pharmaceutical Group Co. Ltd.; Piramal Enterprises Limited; Jiangsu Hengrui Medicine Co. Ltd.; Fresenius Kabi AG, and AbbVie Inc.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Stakeholders
2. Research Methodology
2.1 Research Data
2.1.1 Primary Data
2.1.2 Secondary Data
2.2 Market Size Estimation
2.3 Research Assumptions
3. Executive Summary
4. Industry Insights
5. Global inhalation anesthesia Market – By Product Type
5.1 Sevoflurane
5.2 Isoflurane
5.3 Desflurane
6. Global inhalation anesthesia Market – By Application
6.1 Induction
6.2 Maintenance
7. Global inhalation anesthesia Market – By Geography
7.1 North America
7.1.1 US
7.1.2 Canada
7.2 Europe
7.2.1 Germany
7.2.2 France
7.2.3 UK
7.2.4 Rest of Europe
7.3 Asia-Pacific
7.3.1 Japan
7.3.2 China
7.3.3 India
7.3.4 Rest of APAC
7.4 LAMEA
7.4.1 Latin America
7.4.2 Middle East
7.4.3 Africa
8. Competitive Landscape
9. Company Profiles
9.1 Halocarbon Products Corporation
9.2 Hikima Pharmaceuticals PLC
9.3 Lunan Pharmaceutical Group Co. Ltd.
9.4 Piramal Enterprises Limited
9.5 Jiangsu Hengrui Medicine Co. Ltd.
9.6 Fresenius Kabi AG
9.7 AbbVie Inc.
9.8 Other Players
10. Appendix
List of Tables
Table 1 Global Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 2 Global Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 3 Global Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Region, (US$ Mn AGR%, CAGR%), 2019-2029
Table 4 North America Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 5 North America Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 6 U.S. Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 7 U.S. Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 8 Canada Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 9 Canada Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 10 Europe Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 11 Europe Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 12 Germany Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 13 Germany Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 14 France Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 15 France Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 16 UK Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 17 UK Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 18 Rest of Europe Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 19 Rest of Europe Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 20 Asia-Pacific Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 21 Asia-Pacific Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 22 Japan Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 23 Japan Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 24 China Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 25 China Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 26 India Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 27 India Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 28 Rest of APAC Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 29 Rest of APAC Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 30 LAMEA Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 31 LAMEA Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 32 Latin America Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 33 Latin America Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 34 Middle East Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 35 Middle East Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 36 Africa Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 37 Africa Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
List of Figures
Figure 1 Global Inhalation Anesthesia Hypertension Market: Segmentation
Figure 2 Global Inhalation Anesthesia Hypertension Market: Research Design
Figure 3 Global Inhalation Anesthesia Hypertension Market: 3 Drivers, Restraints, Opportunities, and Challenges
Figure 4 Global Inhalation Anesthesia Hypertension Market: By Product Type
Figure 5 Global Inhalation Anesthesia Hypertension Market: By Application
Figure 6 Global Inhalation Anesthesia Hypertension Market: By Region
Figure 7 North America Inhalation Anesthesia Hypertension Market: Market Snapshot
Figure 8 Europe Inhalation Anesthesia Hypertension Market: Market Snapshot
Figure 9 Asia-Pacific Inhalation Anesthesia Hypertension Market: Market Snapshot
Figure 10 LAMEA Inhalation Anesthesia Hypertension Market: Market Snapshot
Figure 11 Market Share/Ranking : Financial Snapshot
Figure 12 Halocarbon Products Corporation; : Financial Snapshot
Figure 13 Hikima Pharmaceuticals PLC : Financial Snapshot
Figure 14 Lunan Pharmaceutical Group Co. Ltd. : Financial Snapshot
Figure 15 Piramal Enterprises Limited : Financial Snapshot
Figure 16 Jiangsu Hengrui Medicine Co. Ltd. : Financial Snapshot
Figure 17 Fresenius Kabi AG : Financial Snapshot
Figure 18 AbbVie Inc. : Financial Snapshot
AbbVie Inc.
Fresenius Kabi AG
Halocarbon Products Corporation;
Hikima Pharmaceuticals PLC
Jiangsu Hengrui Medicine Co. Ltd.
Lunan Pharmaceutical Group Co. Ltd.
Piramal Enterprises Limited
Download sample pages
Complete the form below to download your free sample pages for Global Inhalation Anaesthesia Market Report 2019-2029Download sample pages
Complete the form below to download your free sample pages for Global Inhalation Anaesthesia Market Report 2019-2029Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
If so, please drop an email to Sara Peerun stating your chosen report title to sara.peerun@visiongain.com
What are the dynamic growth sectors? where are the regional business opportunities?
Which technologies will prevail and who are the leading companies succeeding in these sectors and why?
If you want definitive answers to business critical questions, discover Visiongain’s full range of business intelligence reports.
If so, please email Sara Peerun on sara.peerun@visiongain.com or call her today on +44 (0) 20 7549 9987
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia

Click here to ‘Like’ our Facebook page https://www.facebook.com/V.G.Pharma/
Latest Pharma news
Visiongain Publishes Cancer Diagnostics Market Report 2021-2031
Major investments have been made by companies in the cancer diagnostics industry in the past few years to develop novel tests to capitalize on the opportunities in the untapped market.
19 April 2021
Visiongain Publishes Food for Special Medical Purpose (FSMP) Market Report 2020-2030
The food for special medical purpose (FSMP) market growth can be attributed to the growing prevalence of metabolic diseases, growing consumer unhealthy lifestyle, and surge in demand from emerging economies such as Asia Pacific, Middle East & Africa, Latin America, and others.
12 April 2021
Visiongain Publishes Cell-Based Assays Market Report to 2030
Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are some of the major factors that propel the market growth.
09 April 2021
Visiongain Publishes Cancer Biologics Therapies Market Report 2021-2031
The main drivers for the growth include technological advancements in the development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.
06 April 2021